Monitor the shareholder vote outcome on November 18, 2026. If approved, the board has six months to implement the reverse split at a ratio of its choosing. The company's ability to maintain Nasdaq listing is critical given its $4M market cap and history of non-compliance.
CRIS drugs
CRIS drug pipeline →How the stock moved after the report
NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+5- T+0 · Nov 2 $0.6610entry
- T+1 · 14d ago +8.00%α +7.70% · $0.7139
- T+5 · 8d ago +5.54%α +5.46% · $0.6976
- T+10 · todayOpen
- T+20 · in 14d Pending
- T+60 · in 2mo Pending
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Curis Inc. is holding a special shareholder meeting on November 18, 2026 to vote on two proposals: (1) authorizing a reverse stock split at a ratio between 1-for-5 and 1-for-12 to regain compliance with Nasdaq's minimum bid price requirement, and (2) adjourning the meeting if necessary to solicit additional votes. The company has a market cap of only $4M and has been at risk of delisting, having received a delist determination letter in April 2026 before regaining compliance in July 2026. The filing is a routine proxy solicitation for a reverse split authorization, which is a defensive measure to maintain listing.
Key Facts
- Special meeting scheduled for November 18, 2026 to vote on reverse stock split (ratio range 1-for-5 to 1-for-12) and adjournment proposal.
- As of October 20, 2026, there were 6,679,229 shares of common stock outstanding.
- Company received a Delist Determination Letter from Nasdaq on April 27, 2026 for non-compliance with the $1.00 bid price rule, but regained compliance on July 24, 2026 and is under a Discretionary Panel Monitor until July 24, 2027.
- Board of directors recommends voting FOR both proposals.
- No executive compensation, director elections, shareholder proposals, or related party transactions are being voted on at this special meeting.
- Four 5% stockholders: Bleichroeder LP (9.99%), Stonepine Capital LP (9.99%), Pointillist Partners LLC (8.24%), and entities affiliated with Thomas A. Satterfield, Jr. (6.39%).
Financial Impact
No financial data provided in the filing. The reverse stock split would reduce outstanding shares from 6,679,229 to between 1,335,846 (1-for-5) and 556,603 (1-for-12).
Risk Factors
- Reverse stock split may not permanently increase stock price above $1.00 or maintain Nasdaq compliance.
- Reduced share count could decrease liquidity and result in odd-lot holdings.
- Company has a history of Nasdaq non-compliance and remains under a Discretionary Panel Monitor until July 2027.
- Significant warrant overhang exists, with pre-funded warrants for 15,964,140 shares and common warrants for 23,782,339 shares outstanding as of October 20, 2026.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| DEF 14A Filing (Primary) | 0001140361-26-041419 |
| Document: 0001140361-26-041419-index-headers.html | 0001140361-26-041419 |
| Document: 0001140361-26-041419-index.html | 0001140361-26-041419 |
| Document: 0001140361-26-041419.txt | 0001140361-26-041419 |
Track record
18 reports on CRIS
7 of 9 bullish or bearish reports moved the stock their way by T+1. Best: +82.45% at T+60 after the May 22, 2026 report. 9 of 9 went positive at some point.
Filters
- Nov 16, 2026today SC 13G Neutral 4/10 Entry $0.4200 Now $0.4400 +4.76% settles Nov 17
- Nov 13, 20263d ago SC 13G/A Neutral 3/10 Entry $0.6000 Now $0.4400 −26.67% settles Nov 17
- Nov 13, 20263d ago SC 13G/A Neutral 2/10 Entry $0.5010 Now $0.4400 −12.18% settles Nov 17
- Nov 13, 20263d ago S-3 Bearish 7/10 Entry $0.6000 Now $0.4400 +26.67% settles Nov 17
- Nov 13, 20263d ago 8-K Neutral 4/10 Entry $0.4450 Now $0.4400 −1.12% settles Nov 17
- Nov 12, 20264d ago Press Release Bearish 6/10 Entry $0.4450 to $0.4358 Now $0.4400 +1.12% ▲ +2.07% +0.16% vs SPY
- Nov 10, 20266d ago SC 13G/A Neutral 3/10 Entry $0.6530 to $0.5915 Now $0.4400 −32.62% ▼ −9.42% −10.74% vs SPY
- Nov 6, 202610d ago 8-K Bearish 7/10 Entry $0.6976 to $0.6530 Now $0.4400 +36.93% ▲ +6.39% +6.03% vs SPY
- Nov 2, 202614d ago DEF 14A Neutral 4/10 Viewing Entry $0.6610 to $0.7139 Now $0.4400 −33.43% ▲ +8.00% +7.70% vs SPY
- Oct 19, 202628d ago 8-K Bearish 6/10 Entry $0.3996 to $0.3920 Now $0.4400 −10.11% ▲ +1.90% +2.43% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers